BioPharma Resources

Investigational drug · Phase 3

APG-2575

Also called: lisaftoclax

Not approved by FDA. In 10 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for CLL/SLL, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Phase 3

Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

10

10 still active

All registered trials

27

Any phase or sponsor naming "APG-2575"

First trial start

2020

Aug 31, 2020

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "APG-2575", any sponsor or status.

Conditions studied

As listed on its trial records.

  • CLL/SLL
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Higher-risk Myelodysplastic Syndrome
  • T-Prolymphocytic Leukemia
  • Non-Hodgkins Lymphoma
  • SLE
  • Relapsed/Refractory Acute Myeloid Leukaemia
  • Myeloid Malignancy
  • Neuroblastoma

Approved drugs for the same conditions: Chronic lymphocytic leukemia · Lymphoma (non-Hodgkin) · Myelodysplastic syndromes · Hematology and blood cancers · Rare and genetic disease

Largest trials

Live from ClinicalTrials.gov: studies naming "APG-2575" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 20 on PubMed

Also in development for CLL/SLL

  • CTXPhase 32 trials

    Ascentage Pharma Group Inc. · CLL/SLL, Breast Cancer

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.